Table 1.
Agent name | Description | Tumor model | Research group and reference |
---|---|---|---|
Mn-NEB+BSA | As dual-modal MRI contrast agents, Mn-NEB+BSA could greatly eliminate suspicious artifacts and false-positive signals in mouse brain imaging. | U87MG tumor-bearing athymic nude mice | Jinhao Gao and Xiaoyuan Chen’s group (28) |
DMNF | DMNF showed high tumor-specific MRI with enhanced T1-weighted imaging effect, which was attributed to the synergistic effect of active targeting of AS1411 aptamer and acid-activated release of Mn2+ promoting the MR signal enhancement. | MCF-7 tumor-bearing BALB/c nude mice | Dayong Yang’s group (27) |
HMS | Hollow manganese silicate (HMS) nanoparticles could release Mn2+ in physiological acidic condition as a liver-specific MR contrast agent in hepatic tumor models. | HCC, NEC, and ADC tumor-bearing nude mice | Won Jae Lee and In Su Lee’s group (14) |
Mn, manganese; NEB, 1,4,7-triazacyclononane-N, N’, N’’-triacetic acid conjugated truncated Evans blue; BSA, bovine serum albumin; DMNF, DNA-Mn-based nanoflower; HMS, hollow manganese silicate.